| 2016/12 | AMOEBA announces update of the regulatory calendar in the United States of America |
| 2016/12 | AMOEBA extends its commercial cover with the signature of a new letter of intent with OXIDINE to distribute BIOMEBA in Spain |
| 2016/12 | AMOEBA confirms the submission of its comments to the French regulatory authority |
| 2016/11 | AMOEBA announces receipt of the first draft of the regulatory evaluation report |
| 2016/10 | AMOEBA inaugurates its first industrial site in Lyon - Chassieu |
| 2016/09 | AMOEBA obtains Marketing Authorisation for R&D purposes for 10 industrial sites in Spain |
| 2016/09 | AMOEBA granted Marketing Authorisation for R&D for 10 industrial sites in Germany |
| 2016/09 | Interim financial report 2016 |
| 2016/09 | A Letter of Intent signed with AQUA-SERV in the United States for the distribution of BIOMEBA in three New States |
| 2016/09 | A new Letter of Intent signed with GREEN Chemicals in Brazil |
| 2016/07 | Extension to AMOEBA's portfolio of patents in Japan and Europe |
| 2016/07 | Half-year review of the liquidity contract on 30 June 2016 |
| 2016/06 | Descriptif du programme de rachat d'actions - Assemblée Générale du 22 juin 2016 (In French only) |
| 2016/06 | Update to provisional MA schedule |
| 2016/06 | Availability of preparatory documents for the annual General Meeting on 22nd June 2016 |
| 2016/06 | Information relating to the number of shares and voting rights following a capital increase |
| 2016/05 | AMOEBA raises EUR 14,693,805 million from European and US investors |
| 2016/05 | 29 April 2016: Monitoring council nominates Mrs Gaëtane Suzenet as new independent member |
| 2016/04 | AMOEBA announces publication of its registration document for the 2015 period |
| 2016/04 | AMOEBA obtains market approval for R&D purposes for 10 industrial sites each in Belgium, Italy and the Netherlands |
| 2016/04 | AMOEBA extends protection of its technology to Russia and the USA |
| 2016/04 | AMOEBA announces its participation in the EUROPEAN SMALLCAP EVENT on 11 and 12 April 2016 in Paris |
| 2016/03 | Full-year 2015 results online with the development plan |
| 2016/03 | First launch planned on the Turkish market. signature of a letter of intent with GREEN Chemicals |
| 2016/02 | AMOEBA to gain access to the European market as soon as its solution is validated by ANSES |
| 2016/02 | AMOEBA extends its portfolio of patents in Europe and in the United States |
| 2016/02 | Financial communications calendar 2016 |
| 2016/01 | AMOEBA extends its commercial coverage to Poland |
| 2016/01 | Half-year review of the liquidity contract |
